Michael Mendoza leads the company’s biometrics strategy and oversees the design and execution of data-driven clinical development programs. He is responsible for ensuring that clinical data are structured, integrated, and analyzed to support decision-ready, regulatory-grade evidence.
With more than 28 years of experience across pharmaceutical, biotech, and CRO organizations, Michael brings deep expertise across the full clinical data lifecycle, including study design, data management, statistical analysis, and submission readiness. His work integrates advanced analytics, digital technologies, and scalable data architectures to enable more efficient, insight-driven trials.
Michael has extensive experience implementing systems and strategies across EDC, eCOA, RTSM, CTMS, centralized monitoring, and AI-enabled analytics. He is known for building high-performing global teams and aligning biometrics and data science capabilities with evolving clinical and regulatory expectations, helping sponsors accelerate development timelines while improving data quality and interpretability.
